This hypothesis is supported by scientific findings showing that IL-6 has a protective effect on drug-induced apoptosis treatment in NB cells [14] and that its expression as well the expression of IL-6 receptor is inhibited upon treatment with retinoic acid, currently used agent in NB therapy [18]. The gene discussed is IL6; the disease is neuroblastoma.